Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2122 (LINC02122)

Target
LINC02122
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 2122 (LINC02122) is a member of the long intergenic non-coding RNA (lincRNA) family, a subset of long non-coding RNAs longer than 200 nucleotides that do not overlap protein-coding genomic regions[3][5]. LINC02122 does not encode a protein and is annotated based on its genomic location and transcript structure. Like other lincRNAs, it is presumed to function in the regulation of gene expression, possibly by influencing chromatin state, modulating transcriptional programs, or acting as a scaffold for regulatory complexes; however, no specific biological function, disease association, or drug interactions have been reported for LINC02122 itself in available sources[1][3][5][7]. Most lincRNAs demonstrate tissue-specific expression and can participate in fine-tuning the expression of neighboring genes, but direct functional or therapeutic relevance has not been established for LINC02122. Thus, it should not currently be considered a direct therapeutic target.

Other names
LINC02122long intergenic non-protein coding RNA 2122
02

Biological functions

Regulation of gene expression (generally attributed to lincRNAs)Chromatin remodeling (general attribute of lincRNAs)Transcriptional regulation (general attribute of lincRNAs)Potential enhancer-associated activity (general for some lincRNAs)
03

Disease associations

Other (generic non-coding RNAs are sometimes implicated in cancer, but no evidence is provided for LINC02122 specifically)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2122 (LINC02122).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2122 (LINC02122).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call